Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.

Peltonen JK, Vähäkangas KH, Helppi HM, Bloigu R, Pääkkö P, Turpeenniemi-Hujanen T.

Head Neck Oncol. 2011 Apr 22;3:20. doi: 10.1186/1758-3284-3-20.

PMID:
21513535
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations.

Peltonen JK, Helppi HM, Pääkkö P, Turpeenniemi-Hujanen T, Vähäkangas KH.

Head Neck Oncol. 2010 Dec 15;2:36. doi: 10.1186/1758-3284-2-36.

PMID:
21159183
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM.

N Engl J Med. 2007 Dec 20;357(25):2552-61.

PMID:
18094376
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.

Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.

Oncol Rep. 1998 Sep-Oct;5(5):1053-9.

PMID:
9683807
[PubMed - indexed for MEDLINE]
5.

[Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].

Golusinski P, Lamperska K, Pazdrowski J, Golusinski W.

Otolaryngol Pol. 2011 Mar-Apr;65(2):114-21. doi: 10.1016/S0030-6657(11)70640-0. Polish.

PMID:
21735667
[PubMed - indexed for MEDLINE]
6.

Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.

Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Fukuda H.

Oral Oncol. 2003 Feb;39(2):163-9.

PMID:
12509970
[PubMed - indexed for MEDLINE]
7.

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.

Alsner J, Høyer M, Sørensen SB, Overgaard J.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):519-25.

PMID:
11173149
[PubMed - indexed for MEDLINE]
8.

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.

Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H, Bosch FX.

Oncogene. 1998 Apr 2;16(13):1671-9.

PMID:
9582015
[PubMed - indexed for MEDLINE]
Free Article
9.

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.

Eriksen JG, Alsner J, Steiniche T, Overgaard J.

Radiother Oncol. 2005 Aug;76(2):135-42.

PMID:
16024113
[PubMed - indexed for MEDLINE]
10.

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.

Alsner J, Sørensen SB, Overgaard J.

Radiother Oncol. 2001 May;59(2):179-85.

PMID:
11325447
[PubMed - indexed for MEDLINE]
11.

Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck.

Riedel F, Götte K, Schwalb J, Schäfer C, Hörmann K.

Acta Otolaryngol. 2000 Jan;120(1):105-11.

PMID:
10779196
[PubMed - indexed for MEDLINE]
12.

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

Ganci F, Sacconi A, Bossel Ben-Moshe N, Manciocco V, Sperduti I, Strigari L, Covello R, Benevolo M, Pescarmona E, Domany E, Muti P, Strano S, Spriano G, Fontemaggi G, Blandino G.

Ann Oncol. 2013 Dec;24(12):3082-8. doi: 10.1093/annonc/mdt380. Epub 2013 Oct 9.

PMID:
24107801
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.

Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ.

Laryngoscope. 2014 Jul;124(7):E267-73. doi: 10.1002/lary.24595. Epub 2014 Feb 20.

PMID:
24431303
[PubMed - indexed for MEDLINE]
14.

TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.

Nagai MA, Miracca EC, Yamamoto L, Kowalski LP, Brentani RR.

Am J Surg. 1995 Nov;170(5):492-4.

PMID:
7485740
[PubMed - indexed for MEDLINE]
15.

TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.

Xu L, Davidson BJ, Murty VV, Li RG, Sacks PG, Garin-Chesa P, Schantz SP, Chaganti RS.

Int J Cancer. 1994 Nov 1;59(3):383-7.

PMID:
7927946
[PubMed - indexed for MEDLINE]
16.

Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.

Lindenbergh-van der Plas M, Brakenhoff RH, Kuik DJ, Buijze M, Bloemena E, Snijders PJ, Leemans CR, Braakhuis BJ.

Clin Cancer Res. 2011 Jun 1;17(11):3733-41. doi: 10.1158/1078-0432.CCR-11-0183. Epub 2011 Apr 5.

PMID:
21467160
[PubMed - indexed for MEDLINE]
Free Article
17.

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.

Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J.

Br J Cancer. 1998 Oct;78(8):1084-90.

PMID:
9792155
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.

Nylander K, Dabelsteen E, Hall PA.

J Oral Pathol Med. 2000 Oct;29(9):413-25. Review.

PMID:
11016683
[PubMed - indexed for MEDLINE]
19.

[p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].

Riethdorf S, Friedrich RE, Sühwold J, Ostwald C, Barten M, Gogacz P, Gundlach KK, Schlechte H, Becker J, Bregenzer T, Riethdorf L, Löning T.

Mund Kiefer Gesichtschir. 1998 Jan;2(1):30-4. German.

PMID:
9522570
[PubMed - indexed for MEDLINE]
20.

Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas.

Ma L, Ronai A, Riede UN, Köhler G.

J Cancer Res Clin Oncol. 1998;124(7):389-96.

PMID:
9719502
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk